All Pharma News
price-trendAsk Us
$12B biotech Biosplice lays off 41, axes hair loss asset

$12B biotech Biosplice lays off 41, axes hair loss asset
K. LaHucik FIERCEBIOTECH
09 Feb 2022
Share Share
Samumed Announces Publication of Phase 2 Data on Lorecivivint

Samumed Announces Publication of Phase 2 Data on Lorecivivint
YAHOO
22 May 2020
Share Share
In conversation with Osman Kibar, CEO of Samumed

In conversation with Osman Kibar, CEO of Samumed
Amirah Al Idrus FIERCE BIOTECH
15 Aug 2019
Share Share
Samumed & United Therapeutics Announce License Agreement For IPF Drug Candidate

Samumed & United Therapeutics Announce License Agreement For IPF Drug Candidate
PR NEWSWIRE
17 Sep 2018
Share Share
Samumed, a $12 billion startup, just raised more funding as it plots an IPO

Samumed, a $12 billion startup, just raised more funding as it plots an IPO
Lydia Ramsey BUSINESS INSIDER
07 Aug 2018
Share Share